Guided Therapeutics Inc (GTHP): Capital Expenditures
$2.0K
Year ended 2025-12-31
-59.9%
3-year compound annual growth
+14.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.0K | n/a | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $0 | n/a | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2024-03-28, From 2023-01-01 |
| 2022-12-31 | $31.0K | +121.4% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $14.0K | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $1.0K | n/a | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2021-04-07, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $2.0K | n/a |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $3.8K | +342.0% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $4.02M | -90.1% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $31.1K | +12.1% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $90.0K | +50.0% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $4.4K | +13.9% |
| CapsoVision, Inc (CV) | 2025-12-31 | $90.0K | -41.2% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $1.19M | +209.4% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $124.0K | +40.9% |
Compare GTHP, ITOC, HCIL, NRXS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗